1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
9
Carnegie Strategifond D
Fee
1.50%
ISIN
SE0013525276
Holdings
24
We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Carnegie Strategifond D, we have 34 holdings where Investor is the largest holding (6.12), followed by Essity (4.67) and Volvo (4.4).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Carnegie Strategifond D.
| UBS Lux Equity Fund Biotech USD | Carnegie Strategifond D |
|---|---|
|
10.04 % |
 6.12 % |
|
9.21 % |
4.67 % |
|
8.44 % |
4.4 % |
|
8.08 % |
3.32 % |
 4.91 % |
2.83 % |
|
4.66 % |
2.73 % |
|
4.43 % |
2.7 % |
|
4.13 % |
2.54 % |
|
3.75 % |
2.53 % |
| - |
2.46 % |
| - |
2.4 % |
| - |
 2.12 % |
| - |
1.81 % |
| - |
1.8 % |
| - |
1.73 % |
| - |
1.73 % |
| - |
1.72 % |
| - |
1.71 % |
| - |
1.53 % |
| - |
1.26 % |
| - |
1.16 % |
| - |
1.15 % |
| - |
 1.02 % |
| - |
1.02 % |
The list of fund holdings was last updated on July 25, 2025.
